Chemours to Pay $112 Million to Stop Poisoning Water
Published Date: 6/29/2026
Notice
Summary
The Chemours Company must clean up pollution from three of its factories, especially in West Virginia and New Jersey, where harmful chemicals called PFAS were released. They’ll install new pollution controls, test local drinking water, and spend $90 million on projects to reduce these chemicals. Plus, Chemours will pay a $22.5 million fine. People have 30 days to share their thoughts on this plan before it’s final.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Drinking water testing and supply
If you live near the Parkersburg, West Virginia or Deepwater, New Jersey Chemours plants, you will have your drinking water sampled and, if needed, be provided clean drinking water under the proposed consent decree announced in June 2026. The testing and provision of clean water are explicitly required for communities surrounding those two facilities.
Parkersburg plant must add pollution controls
If you live near the Parkersburg, West Virginia Chemours facility, the company must install pollution control equipment at that plant under the proposed consent decree lodged June 24, 2026 and noticed June 29, 2026. This requirement is intended to reduce releases of PFAS from the Parkersburg facility.
$90M committed to PFAS mitigation
Chemours will spend $90,000,000 on mitigation projects to reduce PFAS at its facilities as part of the proposed consent decree announced in June 2026. The projects will be selected in the future and are intended to reduce PFAS at Chemours facilities, including those in West Virginia, North Carolina, and New Jersey.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160 — Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-12654 — Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
Starting July 24, 2026, O-desmethyltramadol (also called O-DSMT) will be temporarily placed in Schedule I, meaning it’s treated like the most tightly controlled drugs. This affects anyone who makes, sells, studies, or even just possesses it, bringing strict rules and penalties. The move aims to keep people safe while the government studies the drug more closely.
2026-12653 — Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction
The DEA fixed a typo in the official chemical name of bromazolam, a drug they put in the strictest Schedule I category starting March 16, 2026. This correction makes the rules clear for everyone involved, especially law enforcement and drug handlers. No new fees or deadlines, just a clean-up to keep things accurate and official.
2026-12552 — Agency Information Collection Activities; Proposed Collection eComments Requested; Change of Address/Contact Information Form Title-Change of Address/Contact Information Form
The Department of Justice wants to keep collecting updated address and contact info from people involved in immigration cases, but with some improvements based on public feedback. They’re asking for your thoughts by July 23, 2026, to make sure the form is easy and useful. This update won’t cost you extra money but helps keep communication smooth and official.
Previous / Next Documents
Previous: 2026-13080 — Combined Notice of Filings #1
The Federal Energy Regulatory Commission got a bunch of new filings from energy companies about changes in how they connect and charge for electricity. These updates affect companies like Palo Duro Wind, NIPSCO, PJM, and Southwest Power Pool, with some new rates and agreements kicking in as soon as late June and early September 2026. If you’re involved in energy or just curious, keep an eye on deadlines for comments in mid-July—they could impact future energy costs and services.
Next: 2026-13082 — Sunshine Act Meetings
The SEC is holding a closed meeting on July 9, 2026, to discuss important legal and enforcement matters like lawsuits and investigations. Only key officials and some staff will attend, and the public won’t be allowed in. If anything changes, updates will be posted online—no extra costs or delays expected.